Global Tyrosine Kinase Inhibitors Market Forecast Report to 2028, with Profiles of Major Industry Players - ResearchAndMarkets.com

The "Tyrosine Kinase Inhibitors: Global Market Outlook" report has been added to ResearchAndMarkets.com's offering.

Extensive research in the field of tyrosine kinase inhibitors has revealed their target-specific functionality in being able to provide therapeutic treatments for various chronic diseases. Modern industries have now begun to explore the advantages of tyrosine kinase inhibitors in their productions and processes. This has led to a steady market for these substances.

The report describes the current market scenario for tyrosine kinase inhibitors and assesses the market's growth over the period from 2021 through the end of 2028. The study estimates the size of the tyrosine kinase inhibitor market at global and regional levels and explores market dynamics and trends that impact market growth. Types and applications of tyrosine kinase inhibitors are also discussed in the report, with emphasis on the usage of the inhibitors in therapeutic categories and various disease sectors. The report also covers significant patents and provides a summary of patents.

In this report, the market has been segmented based on type, application and geography. The report provides an overview of the global tyrosine kinase inhibitor market and analyzes market trends. The report provides estimated market data for the forecast period of 2023 through 2028. Market values have been estimated based on the total revenue of tyrosine kinase inhibitor product providers.

The Report Includes

• An overview of the global market for tyrosine kinase inhibitors
• Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
• Definition of tyrosine kinase inhibitors and their characteristics, and coverage of the market's dynamics, specifically drivers, inhibitors and opportunities
• Discussions of novel tyrosine kinase inhibitors and their utility in the human trials
• Examination of the technologies and methods used for the creation of novel targets and their therapeutic approaches
• Discussions of market challenges and how to overcome them if the market is to reach its commercialization potential, pipeline drugs and relevant patents
• Information on recent mergers and acquisitions, collaborations, partnerships and product introductions
• Profiles of major players in the market

   

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market Overview

• Kinase Inhibitors
• Types of Kinase Inhibitors
• Tyrosine Kinase Inhibitors
• Regulatory Scenario
• Market Dynamics

Chapter 4 Market Breakdown by Type and Application

• Market for Tyrosine Kinase Inhibitors, by Type
• Receptor Tyrosine Kinase Inhibitors
• Non-receptor Tyrosine Kinase Inhibitors
• Market for Tyrosine Kinase Inhibitors, by Application
• Lung Cancer
• Chronic Myelogenous Leukemia (CML)
• Others

Chapter 5 Market Breakdown by Region

• Global Market for Tyrosine Kinase Inhibitors, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 ESG Development

• The Sustainability of Tyrosine Kinase Inhibitor Manufacturers in the Industry
• Pharma End User Sustainability in the Industry
• Case Study

Chapter 7 Industry Structure

• Ranking of Top Companies
• Pipeline Analysis
• Patent Analysis
• Emerging Trends

Chapter 8 Company Profiles

• Astrazeneca
• Bayer
• Boehringer Ingelheim International
• Bristol-Myers Squibb
• Eisai
• F. Hoffmann-La Roche
• Johnson & Johnson Services
• Novartis
• Pfizer

For more information about this report visit https://www.researchandmarkets.com/r/6db1jk

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240605304016/en/